AptarGroup, Inc. (ATR) stock analysis

Healthcare · Medical Instruments & Supplies

From the 10-K filed 2026-02-06

Business type: Capital compounder

How it makes money

Aptar earns revenue by selling specialized dispensing systems, valves, and active packaging components to approximately 5,000 global customers.

Aptar designs and manufactures drug and consumer product dosing, dispensing, and protection technologies. Its primary offerings include dispensing pumps, closures, aerosol valves, elastomeric primary packaging components, active material science solutions, and digital health solutions. These products serve diverse end markets such as pharmaceuticals, beauty, personal care, home care, food, and beverage.

Profitability is driven by product volume growth across segments and pricing dynamics that compensate for fluctuations in input costs, such as resin. Volume increases in pharmaceutical and closure segments, alongside tooling sales in beauty, directly influence top-line results.

What protects it: the moat

Management claims that proprietary design, engineering, materials science capabilities, and a broad global footprint protect its market position.

Aptar relies on its established global network of manufacturing facilities and long-standing customer relationships across multiple industries. Management asserts that its proprietary polymer-based technologies and shared technology platforms create competitive barriers in drug delivery and consumer product protection. However, the filing presents these advantages largely as management's strategic claims without standalone empirical proof of exclusivity.

What growth costs

The company incurs ongoing capital expenditures, research and development expenses, and acquisition outlays to sustain and expand operations.

Capital expenditures accounted for approximately 7% of sales during the year. In addition to maintaining and expanding physical manufacturing facilities across North America, Europe, Asia, and Latin America, Aptar invests in strategic acquisitions and equity investments, such as the purchase of Sommaplast for $27.0 million and increasing its stake in BTY for approximately $29.0 million. Selling, research, and development, and administrative expenses also represent ongoing reinvestment to support core operations.

What could damage it

A severe deterioration in economic conditions could cause customers to delay or cancel orders, directly impairing operational volume and earnings.

If macroeconomic uncertainty, inflation, rising interest rates, or credit tightening leads businesses and consumers to postpone spending, customers may reduce their demand for Aptar's dosing and dispensing technologies. Because Aptar's earnings depend heavily on continuous product volume across its diversified end markets, reduced order flow from customers would lower manufacturing output and compress operating margins.

About AptarGroup, Inc.

AptarGroup, Inc. designs and manufactures drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, fragrance, facial skincare, color cosmetics, personal care, home care, and food and beverage markets. The company operates through three segments: Pharma, Beauty, and Closures. It provides dispensing pumps used to dispense sprays, liquids, or lotions from non-pressurized containers; fine-mist pumps for pharmaceutical and fragrance applications; and lotion pumps for viscous formulations, as well as closures, such as dispensing and non-dispensing solutions that enable product delivery without removal of the cap and used across various consumer end markets. The company also offers aerosol valves used in pressurized containers and continuous spray and metered-dose valves for pharmaceutical, personal care, and household applications; elastomeric primary packaging components; active material science solutions; and digital health solutions. The company primarily sells its products and services in Asia, Europe, Latin America, and North America. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.

Other companies in Medical Instruments & Supplies